Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Sumitomo Bakelite

TOYO INK SC HOLDINGS

TAKASAGO INTERNATIONAL

Nichi-Iko Pharmaceutical

KANEKA

SAWAI PHARMACEUTICAL

東京応化工業

Dainippon Sumitomo Pharma

NATOCO

Central Glass

小林製薬

SAKATA INX

kyowa Hakko Kirin

Dr.Ci:Labo

TOAGOSEI CO

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

ROHM

NIPPON COKE & ENGINEERING

PIONEER

クラリオン

クラリオン

Financial Indicator Details: 小林製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: 小林製薬 (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	7.04% (-12.05%)	7.15% (-0.50%)	7.13% (1.53%)	8.93% (-1.67%)	10.01% (3.05%)
C/F margin (Industry Average)	10.22% (-3.31%)	11.85% (8.51%)	10.06% (7.04%)	13.15% (6.35%)	7.60% (8.25%)
ROA (Industry Average)	7.07% (0.52%)	7.00% (1.04%)	6.94% (2.07%)	7.92% (0.06%)	7.75% (2.71%)
ROE (Industry Average)	11.59% (-1.43%)	10.93% (0.03%)	10.21% (2.96%)	11.50% (4.68%)	10.59% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	10.78% (5.01%)	7.96% (2.61%)	11.53% (-0.40%)	12.75% (8.16%)
Sales growth (Industry Average)	- (-)	2.77% (-2.67%)	1.26% (5.36%)	0.26% (1.07%)	-7.34% (2.24%)
Net profit growth (Industry Average)	- (-)	4.47% (203.46%)	0.92% (63.25%)	25.61% (3.89%)	3.83% (90.38%)
Operating C/F growth (Industry Average)	- (-)	19.22% (275.10%)	-14.04% (35.09%)	30.99% (-6.09%)	-46.42% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	60.98% (53.80%)	64.10% (54.51%)	67.98% (55.00%)	68.88% (53.59%)	73.11% (56.30%)
Liquidity ratio (Industry Average)	183.69% (217.72%)	218.34% (225.70%)	257.31% (237.55%)	271.32% (239.89%)	273.66% (236.21%)
C/F ratio current liabilities (Industry Average)	310.01% (777.21%)	254.74% (303.31%)	262.18% (434.79%)	219.07% (929.73%)	373.04% (573.30%)
Quick ratio (Industry Average)	126.15% (138.97%)	151.36% (148.85%)	179.12% (156.17%)	198.32% (160.84%)	222.40% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	79.68day (83.89day)	74.58day (94.27day)	83.36day (93.96day)	89.36day (97.92day)	92.55day (98.27day)
Inventory turnover (Industry Average)	37.22day (54.45day)	32.33day (52.58day)	30.39day (52.64day)	33.42day (56.59day)	33.62day (58.68day)
Payable turnover (Industry Average)	45.10day (45.01day)	41.16day (49.82day)	35.93day (49.52day)	35.68day (52.10day)	34.76day (51.12day)
Working capita turnover (Industry Average)	71.79day (93.32day)	65.75day (97.02day)	77.82day (97.08day)	87.10day (102.41day)	91.41day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	18.46% (34.57%)	0.12% (1.49%)	7.39% (-3.85%)	9.78% (21.16%)
Dividend Yield (Industry Average)	1.66% (3.20%)	1.45% (1.93%)	1.64% (2.17%)	1.58% (2.45%)	1.73% (2.07%)
PER (Industry Average)	15.61% (25.22%)	17.70% (23.06%)	17.56% (16.22%)	15.01% (29.19%)	15.87% (16.58%)
PBR (Industry Average)	1.80% (0.86%)	1.93% (1.06%)	1.79% (1.04%)	1.72% (0.95%)	1.68% (1.08%)
PCFR (Industry Average)	10.75% (7.18%)	10.68% (9.23%)	12.44% (-2.43%)	10.20% (9.50%)	20.91% (7.56%)
PSR (Industry Average)	1.09% (0.77%)	1.26% (0.88%)	1.25% (1.10%)	1.34% (0.90%)	1.59% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31
Net profit margin (Industry Average)	7.32% (-5.37%)	7.10% (-10.69%)	6.02% (8.92%)
C/F margin (Industry Average)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	6.87% (1.42%)	6.78% (-0.27%)	5.28% (1.53%)
ROE (Industry Average)	11.11% (1.81%)	10.49% (3.42%)	7.69% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31
Equity growth (Industry Average)	- (3.03%)	9.24% (0.04%)	6.76% (3.91%)
Sales growth (Industry Average)	- (-)	6.26% (0.75%)	-7.71% (-1.74%)
Net profit growth (Industry Average)	- (43.48%)	3.13% (-47.04%)	-21.71% (62.14%)
Operating C/F growth (Industry Average)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31
Capital adequacy (Industry Average)	61.86% (57.17%)	64.66% (55.93%)	68.72% (57.57%)
Liquidity ratio (Industry Average)	165.86% (266.94%)	203.44% (314.47%)	229.62% (233.84%)
C/F ratio current liabilities (Industry Average)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	115.81% (174.83%)	142.30% (228.06%)	164.58% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31
Receivables turnover (Industry Average)	80.26day (95.88day)	73.27day (98.58day)	84.44day (67.18day)
Inventory turnover (Industry Average)	26.82day (47.43day)	21.30day (50.67day)	18.88day (38.21day)
Payable turnover (Industry Average)	46.49day (51.13day)	43.84day (53.57day)	41.15day (34.24day)
Working capita turnover (Industry Average)	60.60day (92.19day)	50.73day (95.69day)	62.17day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31
Market Value growth (Industry Average)	- (3.11%)	18.46% (-3.30%)	0.12% (24.19%)
Dividend Yield (Industry Average)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	16.84% (13.58%)	19.34% (22.26%)	24.74% (26.42%)
PBR (Industry Average)	1.87% (1.17%)	2.02% (1.08%)	1.90% (1.54%)
PCFR (Industry Average)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	1.23% (3.67%)	1.37% (4.37%)	1.49% (10.14%)

Financial Indicator Details: 小林製薬

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	7.04%	7.15%	7.13%	8.93%	10.01%
C/F margin	10.22%	11.85%	10.06%	13.15%	7.60%
ROA	7.07%	7.00%	6.94%	7.92%	7.75%
ROE	11.59%	10.93%	10.21%	11.50%	10.59%
Recurring margin	12.19%	13.21%	14.53%	15.31%	15.36%
EBIT margin	12.95%	11.27%	10.05%	15.04%	15.37%
EBITDA margin	15.23%	13.59%	12.29%	17.12%	17.52%
NOPAT margin	7.77%	6.76%	6.03%	9.02%	9.22%
Sales SG rates	45.24%	44.27%	42.94%	41.65%	42.56%
Sales SG&A rates	42.05%	42.45%	42.82%	43.63%	43.52%
Sales R&D expenses rates	2.67%	3.06%	3.11%	3.34%	3.73%
Sales depreciation rates	2.28%	2.31%	2.24%	2.07%	2.15%
Capital expenditures net sales ratio	-1.75%	-2.03%	-1.42%	-1.33%	-2.06%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	43.20%	-2.16%	34.01%	7.06%
Equity growth	-	10.78%	7.96%	11.53%	12.75%
Total assets growth	-	5.40%	1.80%	10.07%	6.23%
Sales growth	-	2.77%	1.26%	0.26%	-7.34%
Net profit growth	-	4.47%	0.92%	25.61%	3.83%
Operating C/F growth	-	19.22%	-14.04%	30.99%	-46.42%
Recurring profit growth	-	11.33%	11.35%	5.69%	-7.04%
EBIT growth	-	-10.50%	-9.69%	50.01%	-5.36%
EBITDA growth	-	-8.29%	-8.40%	39.62%	-5.17%
NOPAT growth	-	-10.50%	-9.69%	50.01%	-5.36%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	60.98%	64.10%	67.98%	68.88%	73.11%
Liquidity ratio	183.69%	218.34%	257.31%	271.32%	273.66%
C/F ratio current liabilities	310.01%	254.74%	262.18%	219.07%	373.04%
Quick ratio	126.15%	151.36%	179.12%	198.32%	222.40%
Fixed ratio	23.06%	17.46%	15.49%	13.37%	11.95%
D/E ratio	0.84%	2.23%	0.02%	-	-
Loan to Value Ratio	0.51%	1.43%	0.01%	-	-
Business investment C/F ratio	-17.18%	-17.12%	-14.17%	-10.12%	-27.18%
Liabilities with interest growth	-	193.78%	-98.67%	-80.00%	-20.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	66.24day	92.30day	89.17day	119.19day	137.73day
Receivables turnover	79.68day	74.58day	83.36day	89.36day	92.55day
Inventory turnover	37.22day	32.33day	30.39day	33.42day	33.62day
Fixed assets turnover	51.15day	41.75day	39.49day	37.92day	41.23day
Total asset turnover	363.59day	372.87day	374.85day	411.53day	471.84day
Payable turnover	45.10day	41.16day	35.93day	35.68day	34.76day
Capital turnover	10.01day	9.74day	9.62day	9.60day	10.36day
Equity turnover	221.75day	239.03day	254.84day	283.50day	344.99day
Working capita turnover	71.79day	65.75day	77.82day	87.10day	91.41day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 22 B	¥ 32 B	¥ 31 B	¥ 42 B	¥ 45 B
Accounts receivable-trade	¥ 27 B	¥ 26 B	¥ 29 B	¥ 32 B	¥ 30 B
Other Current Assets	¥ 50 B	¥ 52 B	¥ 56 B	¥ 59 B	¥ 48 B
Current Assets	¥ 73 B	¥ 85 B	¥ 88 B	¥ 102 B	¥ 94 B
Tangible Assets	¥ 17 B	¥ 14 B	¥ 14 B	¥ 13 B	¥ 13 B
Intangible Assets	¥ 10 B	¥ 8 B	¥ 5 B	¥ 5 B	¥ 5 B
Investment etc.	¥ 24 B	¥ 23 B	¥ 25 B	¥ 26 B	¥ 43 B
Total Assets	¥ 125 B	¥ 131 B	¥ 134 B	¥ 147 B	¥ 157 B
Current Liabilities	¥ 39 B	¥ 39 B	¥ 34 B	¥ 37 B	¥ 34 B
Fixed Liabilities	¥ 9 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 7 B
Liabilities with interest	¥ 644 M	¥ 1 B	¥ 25 M	¥ 5 M	¥ 4 M
Net Assets	¥ 76 B	¥ 84 B	¥ 91 B	¥ 101 B	¥ 114 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Capital surplus etc.	¥ 72 B	¥ 81 B	¥ 87 B	¥ 98 B	¥ 111 B
Liabilities and net assets	¥ 125 B	¥ 131 B	¥ 134 B	¥ 147 B	¥ 157 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 125 B	¥ 129 B	¥ 130 B	¥ 131 B	¥ 121 B
Cost of Sales	¥ 56 B	¥ 57 B	¥ 56 B	¥ 54 B	¥ 51 B
Gross profit	¥ 68 B	¥ 71 B	¥ 74 B	¥ 76 B	¥ 69 B
Other income	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 5 B
SG&A	¥ 52 B	¥ 54 B	¥ 56 B	¥ 57 B	¥ 52 B
Other expenses	¥ 9 B	¥ 9 B	¥ 11 B	¥ 10 B	¥ 10 B
Net income	¥ 8 B	¥ 9 B	¥ 9 B	¥ 11 B	¥ 12 B
Operating income	¥ 15 B	¥ 17 B	¥ 18 B	¥ 19 B	¥ 16 B
Ordinary Income	¥ 15 B	¥ 17 B	¥ 19 B	¥ 20 B	¥ 18 B
EBITDA	¥ 19 B	¥ 17 B	¥ 16 B	¥ 22 B	¥ 21 B
Income before income taxes	¥ 16 B	¥ 14 B	¥ 13 B	¥ 19 B	¥ 18 B
Depreciation	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
R&D expenses	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Income taxes	¥ 7 B	¥ 5 B	¥ 3 B	¥ 8 B	¥ 6 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 12 B	¥ 15 B	¥ 13 B	¥ 17 B	¥ 9 B
Investment CF	¥ -1 B	¥ -4 B	¥ -8 B	¥ -2 B	¥ -26 B
Financial CF	¥ -4 B	¥ -1 B	¥ -5 B	¥ -3 B	¥ -3 B
Foreign Exchange Effects	¥ -372 M	¥ 6 M	¥ -295 M	¥ -154 M	¥ 578 M
Net Change in Cash	¥ 6 B	¥ 8 B	¥ -660 M	¥ 10 B	¥ -20 B
Free CF	¥ 11 B	¥ 10 B	¥ 4 B	¥ 14 B	¥ -17 B
Capital expenditures	¥ -2 B	¥ -2 B	¥ -1 B	¥ -1 B	¥ -2 B
Cash dividends paid	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B	¥ -3 B
Repayment loans	-	-	¥ -175 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -2 B	¥ -2 B	¥ -3 B
Net income	¥ 8 B	¥ 9 B	¥ 9 B	¥ 11 B	¥ 12 B
Purchase of treasury stock	¥ -1 B	¥ 6 M	-	¥ -1 M	¥ -1 M
Other Change in Stockholders Equity	¥ 1 M	¥ 1 M	-	-	-
Other Change in Net Assets	¥ -5 B	¥ 1 B	¥ 106 M	¥ 1 B	¥ 4 B
Net Change in Net Assets	¥ -818 M	¥ 8 B	¥ 6 B	¥ 10 B	¥ 12 B

Financial Indicator Details: 小林製薬

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31
Profitability
Net profit margin	7.32%	7.10%	6.02%
C/F margin	-	-	-
ROA	6.87%	6.78%	5.28%
ROE	11.11%	10.49%	7.69%
Recurring margin	14.17%	13.24%	13.94%
EBIT margin	13.09%	10.66%	7.76%
EBITDA margin	13.64%	11.29%	8.26%
NOPAT margin	7.85%	6.40%	4.65%
Sales SG rates	47.70%	47.86%	47.46%
Sales SG&A rates	39.08%	39.34%	39.27%
Sales R&D expenses rates	2.62%	3.05%	3.32%
Sales depreciation rates	0.55%	0.62%	0.50%
Capital expenditures net sales ratio	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31
Growth
Growth rate of cash	-	46.15%	-1.83%
Equity growth	-	9.24%	6.76%
Total assets growth	-	4.50%	0.46%
Sales growth	-	6.26%	-7.71%
Net profit growth	-	3.13%	-21.71%
Operating C/F growth	-	-	-
Recurring profit growth	-	-0.67%	-2.83%
EBIT growth	-	-13.39%	-32.87%
EBITDA growth	-	-12.06%	-32.43%
NOPAT growth	-	-13.39%	-32.87%
Operating expenses growth	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31
Stability
Capital adequacy	61.86%	64.66%	68.72%
Liquidity ratio	165.86%	203.44%	229.62%
C/F ratio current liabilities	-	-	-
Quick ratio	115.81%	142.30%	164.58%
Fixed ratio	13.35%	9.27%	8.06%
D/E ratio	-	1.85%	-
Loan to Value Ratio	-	1.20%	-
Business investment C/F ratio	-	-	-
Liabilities with interest growth	-	-	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31
Turnover
Cash turnover	66.12day	90.95day	96.73day
Receivables turnover	80.26day	73.27day	84.44day
Inventory turnover	26.82day	21.30day	18.88day
Fixed assets turnover	32.11day	22.93day	23.05day
Total asset turnover	388.71day	382.27day	416.14day
Payable turnover	46.49day	43.84day	41.15day
Capital turnover	11.23day	10.57day	11.45day
Equity turnover	240.47day	247.21day	285.99day
Working capita turnover	60.60day	50.73day	62.17day
Indicator	2009-03-31	2010-03-31	2011-03-31
Balance sheet
Cash etc.	¥ 20 B	¥ 29 B	¥ 29 B
Accounts receivable-trade	¥ 24 B	¥ 23 B	¥ 25 B
Other Current Assets	¥ 44 B	¥ 46 B	¥ 46 B
Current Assets	¥ 64 B	¥ 76 B	¥ 76 B
Tangible Assets	¥ 9 B	¥ 7 B	¥ 6 B
Intangible Assets	¥ 2 B	¥ 2 B	¥ 1 B
Investment etc.	¥ 42 B	¥ 38 B	¥ 40 B
Total Assets	¥ 119 B	¥ 124 B	¥ 125 B
Current Liabilities	¥ 38 B	¥ 37 B	¥ 33 B
Fixed Liabilities	¥ 6 B	¥ 6 B	¥ 6 B
Liabilities with interest	-	¥ 1 B	-
Net Assets	¥ 73 B	¥ 80 B	¥ 86 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 B
Capital surplus etc.	¥ 70 B	¥ 77 B	¥ 82 B
Liabilities and net assets	¥ 119 B	¥ 124 B	¥ 125 B
Indicator	2009-03-31	2010-03-31	2011-03-31
Income statement
Sales	¥ 112 B	¥ 119 B	¥ 109 B
Cost of Sales	¥ 53 B	¥ 57 B	¥ 52 B
Gross profit	¥ 58 B	¥ 62 B	¥ 57 B
Other income	¥ 4 B	¥ 2 B	¥ 2 B
SG&A	¥ 43 B	¥ 46 B	¥ 43 B
Other expenses	¥ 10 B	¥ 9 B	¥ 10 B
Net income	¥ 8 B	¥ 8 B	¥ 6 B
Operating income	¥ 14 B	¥ 14 B	¥ 14 B
Ordinary Income	¥ 15 B	¥ 15 B	¥ 15 B
EBITDA	¥ 15 B	¥ 13 B	¥ 9 B
Income before income taxes	¥ 14 B	¥ 12 B	¥ 8 B
Depreciation	¥ 624 M	¥ 744 M	¥ 558 M
R&D expenses	¥ 2 B	¥ 3 B	¥ 3 B
Income taxes	¥ 6 B	¥ 4 B	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31
Cash flow statement
Operating CF	-	-	-
Investment CF	-	-	-
Financial CF	-	-	-
Foreign Exchange Effects	-	-	-
Net Change in Cash	-	-	-
Free CF	-	-	-
Capital expenditures	-	-	-
Cash dividends paid	-	-	-
Repayment loans	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31
Shareowners' equity
Issuance of new shares	-	-	-
Dividends from surplus	¥ -2 B	¥ -2 B	¥ -2 B
Net income	¥ 8 B	¥ 8 B	¥ 6 B
Purchase of treasury stock	¥ -1 B	¥ -1 M	-
Other Change in Stockholders Equity	¥ -1 M	-	¥ -1 M
Other Change in Net Assets	¥ -2 B	¥ 736 M	¥ 1 B
Net Change in Net Assets	¥ 1 B	¥ 6 B	¥ 5 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 小林製薬 (Annual )

Statement Type

Annual : 小林製薬

First quarter : 小林製薬

Second quarter : 小林製薬

Third quarter : 小林製薬

Analysis Menu

Outline : 小林製薬

Statement : 小林製薬

Rating : 小林製薬

Indicator : 小林製薬

Download : 小林製薬

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
小林製薬	4967	TSE 1st	Chemicals	3	Annual	AA

Related Company

TAIYO HOLDINGS (Sales ¥ 36 B)

KANEKA (Sales ¥ 476 B)

日油 (Sales ¥ 148 B)

TAKASAGO INTERNATIONAL (Sales ¥ 118 B)

TOWA PHARMACEUTICAL (Sales ¥ 55 B)

Dr.Ci:Labo (Sales ¥ 33 B)

Sumitomo Bakelite (Sales ¥ 183 B)

MANDOM (Sales ¥ 60 B)

Noevir Holdings (Sales ¥ 46 B)

小林製薬 (Sales ¥ 121 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

SAKATA INX (Sales ¥ 123 B)

Central Glass (Sales ¥ 173 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .